Kamran Badizadegan

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Venues

Expert review of vaccines

Risk analysis : an official publication of the Society for Risk Analysis

Pathogens (Basel, Switzerland)

The Journal of infectious diseases

KidRisk, Inc.

Massachusetts Institute of Technology (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

KidRisk, Inc.

United States

Vice President

Education History

Massachusetts Institute of Technology

United States

BSC :: Chemical Engineering

Publications

Kimberly M Thompson, Kamran Badizadegan
Review of Poliovirus Transmission and Economic Modeling to Support Global Polio Eradication: 2020-2024. Pathogens (Basel, Switzerland) 13 (6) (2024)
Kimberly M Thompson, Kamran Badizadegan
Evolution of global polio eradication strategies: targets, vaccines, and supplemental immunization activities (SIAs). Expert review of vaccines 23 (1) (2024)
Kimberly M Thompson, Kamran Badizadegan
Evolution of global polio eradication strategies: targets, vaccines, and supplemental immunization activities (SIAs). Expert review of vaccines (2024)
Kimberly M Thompson, Kamran Badizadegan
Review of Poliovirus Transmission and Economic Modeling to Support Global Polio Eradication: 2020-2024. Pathogens (Basel, Switzerland) 13 (6) (2024)
Kimberly M Thompson, Kamran Badizadegan
Review of Poliovirus Transmission and Economic Modeling to Support Global Polio Eradication: 2020-2024. Pathogens (Basel, Switzerland) 13 (6) (2024)
Kimberly M Thompson, Kamran Badizadegan
Evolution of global polio eradication strategies: targets, vaccines, and supplemental immunization activities (SIAs). Expert review of vaccines 23 (1) (2024)
Dominika A Kalkowska, Steven G F Wassilak, Eric Wiesen, Cara C Burns, Mark A Pallansch, Kamran Badizadegan, Kimberly M Thompson
Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences. Risk analysis : an official publication of the Society for Risk Analysis (2023)
Dominika A Kalkowska, Eric Wiesen, Steven G F Wassilak, Cara C Burns, Mark A Pallansch, Kamran Badizadegan, Kimberly M Thompson
Worst-case scenarios: Modeling uncontrolled type 2 polio transmission. Risk analysis : an official publication of the Society for Risk Analysis (2023)
Kimberly M Thompson, Dominika A Kalkowska, Janell A Routh, I Ravi Brenner, Eli S Rosenberg, Jane R Zucker, Marisa Langdon-Embry, David E Sugerman, Cara C Burns, Kamran Badizadegan
Modeling poliovirus transmission and responses in New York State. The Journal of infectious diseases (2023)
Kimberly M Thompson, Kamran Badizadegan
Health economic analyses of secondary vaccine effects: a systematic review and policy insights. Expert review of vaccines 21 (3) (2022)
Dominika A Kalkowska, Kamran Badizadegan, Kimberly M Thompson
Modeling scenarios for ending poliovirus transmission in Pakistan and Afghanistan. Risk analysis : an official publication of the Society for Risk Analysis (2022)
Kimberly M Thompson, Dominika A Kalkowska, Kamran Badizadegan
Health economic analysis of vaccine options for the polio eradication endgame: 2022-2036. Expert review of vaccines 21 (11) (2022)
Dominika A Kalkowska, Kamran Badizadegan, Kimberly M Thompson
Modeling undetected live type 1 wild poliovirus circulation after apparent interruption of transmission: Pakistan and Afghanistan. Risk analysis : an official publication of the Society for Risk Analysis (2022)
Kamran Badizadegan, Dominika A Kalkowska, Kimberly M Thompson
Polio by the Numbers-A Global Perspective. The Journal of infectious diseases 226 (8) (2022)
Kimberly M Thompson, Dominika A Kalkowska, Kamran Badizadegan
Hypothetical emergence of poliovirus in 2020: part 1. Consequences of policy decisions to respond using nonpharmaceutical interventions. Expert review of vaccines 20 (4) (2021)
Kimberly M Thompson, Dominika A Kalkowska, Kamran Badizadegan
Hypothetical emergence of poliovirus in 2020: part 2. exploration of the potential role of vaccines in control and eradication. Expert review of vaccines 20 (4) (2021)
Kamran Badizadegan, David M Vanlandingham, Wesley Hampton, Kimberly M Thompson
Value of biopsy in a cohort of children with high-titer celiac serologies: observation of dynamic policy differences between Europe and North America. BMC health services research 20 (1) (2020)
Dominika A Kalkowska, Mark A Pallansch, Amanda Wilkinson, Ananda Sankar Bandyopadhyay, Jennifer L Konopka-Anstadt, Cara C Burns, M Steven Oberste, Steven G F Wassilak, Kamran Badizadegan, Kimberly M Thompson
Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain. Risk analysis : an official publication of the Society for Risk Analysis 41 (2) (2020)

Kamran Badizadegan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kamran Badizadegan